%0 Journal Article
%T Clostridium difficile infection in pediatric patients (Review).
%A Dop D
%A Marcu IR
%A Padureanu V
%A Caragea DC
%A Padureanu R
%A Niculescu SA
%A Niculescu CE
%J Biomed Rep
%V 20
%N 2
%D 2024 Feb
%M 38169799
暂无%R 10.3892/br.2023.1706
%X Clostridium difficile (C. difficile) infection (CDI) is the most common cause of healthcare-associated diarrhea and among adults, the worldwide incidence rate of the infection is increasing. There is a small amount of data in the literature for pediatric patients, but most indicate an increasing trend. C. difficile is a constituent of the normal microbiota; however, under specific conditions that cause a disruption of the normal bacterial flora, colonization of C. difficile and the released toxins that cause inflammation and mucosal damage occurs. Risk factors for CDI at any age include hospitalization, exposure to antibiotics, administration of proton pump inhibitors, invasive mechanical ventilation, immunosuppression and presence of associated comorbidities. Clinical manifestations range from asymptomatic colonization to fulminant disease characterized by toxic megacolon, intestinal perforation and, rarely, death. The aim of the present review was to outline the features of CDI in pediatric patients.